Published in Mol Cell Biol on January 13, 2014
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med (2015) 1.17
Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies. J Parkinsons Dis (2016) 0.97
The kinome 'at large' in cancer. Nat Rev Cancer (2016) 0.88
The kinase ABL phosphorylates the microprocessor subunit DGCR8 to stimulate primary microRNA processing in response to DNA damage. Sci Signal (2015) 0.83
Multifunctional Abl kinases in health and disease. J Cell Sci (2016) 0.83
Defying c-Abl signaling circuits through small allosteric compounds. Front Genet (2014) 0.79
Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases. Blood (2016) 0.77
Attacking the supply wagons to starve cancer cells to death. FEBS Lett (2016) 0.77
Opium induces apoptosis in Jurkat cells via promotion of pro-apoptotic and inhibition of anti-apoptotic molecules. Iran J Basic Med Sci (2016) 0.75
Nuclear Translocation of Crk Adaptor Proteins by the Influenza A Virus NS1 Protein. Viruses (2016) 0.75
Phosphotyrosine profiling of curcumin-induced signaling. Clin Proteomics (2016) 0.75
VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation. J Exp Med (2017) 0.75
Structure of the ABL2/ARG kinase in complex with dasatinib. Acta Crystallogr F Struct Biol Commun (2015) 0.75
TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1. Sci Adv (2016) 0.75
EnABLing microprocessor for apoptosis. Mol Cell Oncol (2015) 0.75
Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells. Oncotarget (2016) 0.75
Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells. Oncotarget (2016) 0.75
Neutrophil FcγRIIA promotes IgG-mediated glomerular neutrophil capture via Abl/Src kinases. J Clin Invest (2017) 0.75
Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune Diabetes. Cell Metab (2017) 0.75
G-protein Gα13 Functions with Abl Kinase to Regulate Actin Cytoskeletal Reorganization. J Mol Biol (2017) 0.75
Amplification of F-Actin Disassembly and Cellular Repulsion by Growth Factor Signaling. Dev Cell (2017) 0.75
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell (1991) 14.23
Identification of a ten-amino acid proline-rich SH3 binding site. Science (1993) 8.05
Crystal structure of the Src family tyrosine kinase Hck. Nature (1997) 7.66
Three-dimensional structure of the tyrosine kinase c-Src. Nature (1997) 7.62
Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell (2003) 5.44
Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell (1999) 5.09
Translation of the Philadelphia chromosome into therapy for CML. Blood (2008) 4.74
Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature (1997) 4.26
A myristoyl/phosphotyrosine switch regulates c-Abl. Cell (2003) 3.48
A Src-like inactive conformation in the abl tyrosine kinase domain. PLoS Biol (2006) 3.40
Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron (1998) 3.20
Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol (2004) 3.10
The CTD code. Nat Struct Biol (2003) 3.00
Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature (1997) 2.98
A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell (1993) 2.80
Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc Natl Acad Sci U S A (1998) 2.73
Interaction between ATM protein and c-Abl in response to DNA damage. Nature (1997) 2.70
JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat Cell Biol (2005) 2.56
Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev (1994) 2.54
Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat Med (2001) 2.51
Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell (2008) 2.46
Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell (2008) 2.38
New insights into the regulation and cellular functions of the ARP2/3 complex. Nat Rev Mol Cell Biol (2012) 2.25
Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem (1996) 2.23
Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc Natl Acad Sci U S A (1996) 2.19
Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell (1991) 2.19
CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer. Cancer Res (2013) 2.19
A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol Cell Biol (1993) 2.18
c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines. J Biol Chem (2000) 2.17
Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc Natl Acad Sci U S A (1993) 2.17
KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling. Nature (2013) 2.17
Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases. J Cell Sci (2003) 2.10
Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol (1991) 2.06
CTD tyrosine phosphorylation impairs termination factor recruitment to RNA polymerase II. Science (2012) 2.05
Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes Dev (1995) 2.04
Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev (1995) 2.02
The nucleoskeleton as a genome-associated dynamic 'network of networks'. Nat Rev Mol Cell Biol (2011) 2.01
An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J (1993) 2.00
Role of ABL family kinases in cancer: from leukaemia to solid tumours. Nat Rev Cancer (2013) 1.92
ABL tyrosine kinases: evolution of function, regulation, and specificity. Sci Signal (2010) 1.91
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc Natl Acad Sci U S A (2010) 1.81
Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin. Genes Dev (1996) 1.80
Inhibition of c-Abl tyrosine kinase activity by filamentous actin. J Biol Chem (2001) 1.71
The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J (1996) 1.60
Abl family kinases modulate T cell-mediated inflammation and chemokine-induced migration through the adaptor HEF1 and the GTPase Rap1. Sci Signal (2012) 1.57
Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev (1995) 1.50
The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse. Blood (2008) 1.48
Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor. J Biol Chem (2006) 1.38
Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals. Mol Biol Cell (2004) 1.32
The role of apoptosis-induced proliferation for regeneration and cancer. Cold Spring Harb Perspect Biol (2012) 1.28
Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain. PLoS Comput Biol (2006) 1.27
Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components. J Biol Chem (2008) 1.25
Controlling Abl: auto-inhibition and co-inhibition? Nat Cell Biol (2004) 1.21
Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl. Mol Cell (2005) 1.21
ABL1 regulates spindle orientation in adherent cells and mammalian skin. Nat Commun (2012) 1.20
c-Abl in neurodegenerative disease. J Mol Neurosci (2011) 1.15
Role of c-Abl in the DNA damage stress response. Cell Res (2005) 1.15
A kinase-independent function of c-Abl in promoting proteolytic destruction of damaged DNA binding proteins. Mol Cell (2006) 1.14
Membrane and actin dynamics interplay at lamellipodia leading edge. Curr Opin Cell Biol (2013) 1.07
Abl tyrosine kinases in T-cell signaling. Immunol Rev (2009) 1.04
Abl kinases are required for vascular function, Tie2 expression, and angiopoietin-1-mediated survival. Proc Natl Acad Sci U S A (2013) 1.01
Genetic disruption of Abl nuclear import reduces renal apoptosis in a mouse model of cisplatin-induced nephrotoxicity. Cell Death Differ (2013) 1.00
Coordination of repair, checkpoint, and cell death responses to DNA damage. Adv Protein Chem (2004) 1.00
Mitophagy and Parkinson's disease: be eaten to stay healthy. Mol Cell Neurosci (2012) 0.98
Neuroprotective efficacy of a new brain-penetrating C-Abl inhibitor in a murine Parkinson's disease model. PLoS One (2013) 0.97
Tip60-mediated acetylation activates transcription independent apoptotic activity of Abl. Mol Cancer (2011) 0.97
Abl family tyrosine kinases are essential for basement membrane integrity and cortical lamination in the cerebellum. J Neurosci (2010) 0.97
Phosphoregulation of the WAVE regulatory complex and signal integration. Semin Cell Dev Biol (2013) 0.96
Binding of A/T-rich DNA by three high mobility group-like domains in c-Abl tyrosine kinase. J Biol Chem (1996) 0.96
PUMA, a critical mediator of cell death--one decade on from its discovery. Cell Mol Biol Lett (2012) 0.96
Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function. Genes Cancer (2012) 0.93
Role of Abl in airway hyperresponsiveness and airway remodeling. Respir Res (2013) 0.92
c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression. Nat Cell Biol (2012) 0.92
An evolutionarily acquired genotoxic response discriminates MyoD from Myf5, and differentially regulates hypaxial and epaxial myogenesis. EMBO Rep (2011) 0.92
Synaptic clustering of PSD-95 is regulated by c-Abl through tyrosine phosphorylation. J Neurosci (2010) 0.92
Delayed activation of Bax by DNA damage in embryonic stem cells with knock-in mutations of the Abl nuclear localization signals. Cell Death Differ (2007) 0.91
Interplay between kinase domain autophosphorylation and F-actin binding domain in regulating imatinib sensitivity and nuclear import of BCR-ABL. PLoS One (2011) 0.90
Tyrosine kinase inhibition facilitates autophagic SNCA/α-synuclein clearance. Autophagy (2013) 0.87
c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis. J Biol Chem (2013) 0.87
Regulation of neuronal cell death by c-Abl-Hippo/MST2 signaling pathway. PLoS One (2012) 0.87
c-Abl tyrosine kinase is not essential for ataxia telangiectasia mutated functions in chromosomal maintenance. J Biol Chem (2000) 0.80
Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors. Leuk Res (2013) 0.79
The presence of the Rb c-box peptide in the cytoplasm inhibits p210bcr-abl transforming function. Oncogene (1999) 0.77